Quarterly report pursuant to Section 13 or 15(d)

Intangibles, net (Narrative) (Details)

v3.22.2.2
Intangibles, net (Narrative) (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Finite-Lived Intangible Assets [Line Items]        
Purchase of intangible asset     $ 0 $ 400
Dermira, Inc. a subsidiary of Eli Lilly [Member]        
Finite-Lived Intangible Assets [Line Items]        
Payments of milestones     7,500  
Journey [Member]        
Finite-Lived Intangible Assets [Line Items]        
Payments of milestones     10,000  
Amortization of intangible assets $ 1,000 $ 700 $ 3,100 $ 2,000
Minimum [Member] | Journey [Member]        
Finite-Lived Intangible Assets [Line Items]        
Intangible assets, estimated useful lives     3 years  
Maximum [Member] | Journey [Member]        
Finite-Lived Intangible Assets [Line Items]        
Intangible assets, estimated useful lives     9 years